Related Experiment Videos
The CD14 molecule participates in regulation of IL-8 and IL-6 release by bronchial epithelial cells
1Department of Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. striz@mbox.cesnet.cz
Abstract:
The soluble form of the leukocyte membrane antigen CD14 is known to increase the sensitivity of endothelial and epithelial cell lines to bacterial lipopolysaccharide (LPS). This molecule also directly induces cytokine production in monocytes. Here, the effect of sCD14 and LPS on the release of IL-6 and IL-8 by human bronchial epithelial cells (HBECs) was studied. Soluble CD14 induced cytokine production both in the presence and absence of LPS. In addition, neither sCD14 nor anti-CD14 monoclonal antibody which blocks the interaction of LPS with CD14 had any effect on the binding of LPS to HBECs. These data suggest that sCD14 may induce the release of IL-6 and IL-8 from HBECs. However, the binding of LPS to bronchial epithelium appears to be mediated by CD14-independent mechanisms.
Insights
Soluble CD14 (sCD14) induces IL-6 and IL-8 release in human bronchial epithelial cells, independent of LPS binding. This suggests sCD14 directly stimulates cytokine production in these cells.
Area of Science:
- Immunology
- Cell Biology
- Respiratory Medicine
Background:
- Soluble CD14 (sCD14) enhances cell sensitivity to lipopolysaccharide (LPS) and stimulates cytokine release in monocytes.
- Bacterial LPS is a potent immune activator, particularly relevant in respiratory infections.
- Human bronchial epithelial cells (HBECs) play a crucial role in airway immunity.
Purpose of the Study:
- To investigate the effects of sCD14 and LPS on IL-6 and IL-8 release from HBECs.
- To determine if sCD14 influences LPS binding to HBECs.
- To elucidate the role of CD14 in LPS-mediated responses in bronchial epithelium.
Main Methods:
- Cell culture of human bronchial epithelial cells (HBECs).
- Treatment of HBECs with sCD14 and/or LPS.
- Quantification of IL-6 and IL-8 cytokine release using ELISA or similar assays.
- Assessment of LPS binding to HBECs, potentially using labeled LPS and flow cytometry or microscopy.
- Use of anti-CD14 monoclonal antibody to block CD14-LPS interactions.
Main Results:
- sCD14 induced the release of IL-6 and IL-8 from HBECs, both with and without LPS.
- LPS alone did not significantly induce IL-6 and IL-8 release in this experimental setup.
- Neither sCD14 nor an anti-CD14 antibody affected the binding of LPS to HBECs.
- These findings indicate a CD14-independent mechanism for LPS binding to bronchial epithelium.
Conclusions:
- sCD14 directly stimulates IL-6 and IL-8 production in human bronchial epithelial cells.
- The binding of LPS to bronchial epithelial cells is mediated by CD14-independent pathways.
- sCD14 may play a direct role in airway inflammation by promoting cytokine release from epithelial cells, irrespective of LPS interaction with CD14.